LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
LY3298176 a novel dual GIP and GLP-1 receptor antagonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept